Acerca de
Dr. Ali Chamseddine is a Consultant Medical Oncologist from France, holding dual board certifications in medical oncology and clinical haematology, as well as MD and PhD degrees. He gained expertise at the esteemed Gustave Roussy Cancer Center in Villejuif, France, where he served as a senior medical oncology consultant. Dr. Chamseddine further honed his skills through a post-doctoral fellowship at the Division of Cancer Medicine, Leukaemia Department, at the renowned MD Anderson Cancer Center in Houston, Texas, USA.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Ali Chamseddine
Educación y formación
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Oncología
Carrera y nombramientos
-
2017-09–2018-08 Junior consultant
Licencias y seguros
Licencias médicas
AE — Organización Médica Colegial de España (OMC)
Certificaciones del consejo
European Board of Oncología
Seguro de responsabilidad profesional:
Allianz Professional · 5,000,000 EUR cobertura · No claims on file
Procedimientos realizados
| Procedimiento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 130 |
| Annual physical exam | 99395 | 2,884 |
| Vaccination administration | 90471 | 1,828 |
| Minor procedure (skin) | 17110 | 1,267 |
Servicios y precios
| Servicio | Duración | Modalidad | Precio |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 360.00 EUR |
Consulta, equipo y en práctica
Vídeos
Investigación y publicaciones
índice h: 11 · i10: 3
-
Validation of clinical scoring in Oncología
DOI: 10.7129/euroclin.2026.0 · PMID: 37579667 · citado por 130
-
Long-term follow-up of Oncología across AE
DOI: 10.5594/euroclin.2025.1 · PMID: 31987343 · citado por 200
-
Validation of clinical scoring in Oncología
DOI: 10.6633/euroclin.2024.2 · PMID: 37865520 · citado por 118
Conferencias invitadas
- Practical updates in Oncología European Annual Congress (Oncología) · Vienna · 2024 · invited
- Single-centre experience in Oncología National Society Meeting · Dubai · 2023 · oral abstract
Premios y afiliaciones
Premios
- 🏆 Top-rated Oncología — Dubai · EuroClinics Patient Choice · 2025 · regional
Membresías en sociedades
- WONCA Europe — Family Doctors — Member · Desde 2018
- national college of family doctors — Member · Desde 2018
- European Union of Medical Specialists (UEMS) — Member · Desde 2018
Artículos de este doctor
- Patient education Patient guide to Oncología
- Awareness When should you see a oncología?
Para pacientes internacionales
- Coordinador
- Patient liaison · ali.chamseddine@euroclinics.example
Ubicación
1 etiquetaReseñas de pacientes
Comparta su experiencia — ayude a otros pacientes a encontrar el médico adecuado. Escribir una reseña →
Reseñas recientes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.